DNLI SG&A Expenses

Denali Therapeutics Inc · SG&A Expenses

DNLI logo

DNLI SG&A Expenses

Latest reported$139.03M
DNLI SG&A Expenses ($5.11M → $139.03M)
High-resolution chart · PNG

DNLI sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
97,104,000
105,438,000
103,354,000
90,475,000
79,059,000
60,326,000
46,480,000
32,349,000
15,680,000
11,731,000
5,108,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.